Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
January 18, 2000

Spectrum Laboratory Products Recalls Dihydroergotamine Mesylate Powder

Gardena, CA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Spectrum Laboratory Products, Inc. is recalling Dihydroergotamine Mesylate Powder because of possible cross contamination with cefadroxil.

The recalled prescription bulk active ingredient was distributed in 250 mg, 1 g and 5 g containers and can be identified by the lot numbers NL0465, OC0650 or OG0622.  The expiration date  for all lots is EXP 05/31/02. 

According to FDA, the product was distributed in California, Colorado, Georgia, North Carolina, Oregon, Rhode Island, Texas and Utah.

This ongoing Class II recall was initiated by Spectrum Laboratory by letter on December 10, 1999, followed by telephone on or about December 27, 1999.   This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #D-201-0

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.